on October 1, 2018, Sonoma Pharmaceuticals, Inc. restructured certain business units. The company expanded the role of its Chief Operating Officer, Mr. Marc Umscheid, to include certain oversight functions of its dermatology unit. The company also promoted Mr. Tom Devine to be their General Manager for their re-branded Sonoma Dermatology unit, which was previously IntraDerm Pharmaceuticals. The company promoted Melissa With to be their General Manager of their Acute Care and Trade unit. On October 1, 2018, the company terminated the President of its dermatology unit, Mr. Jeffrey Day, effective immediately.